Cellectar Biosciences Price to Sales Ratio 2010-2025 | CLRB
Cellectar Biosciences P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-07-08 | 4.70 | 0.00 | |
2025-03-31 | 9.46 | 0 | 0.00 |
2024-12-31 | 8.97 | 0 | 0.00 |
2024-09-30 | 64.20 | 0 | 0.00 |
2024-06-30 | 75.00 | 0 | 0.00 |
2024-03-31 | 119.40 | 0 | 0.00 |
2023-12-31 | 83.10 | 0 | 0.00 |
2023-09-30 | 79.20 | 0 | 0.00 |
2023-06-30 | 58.50 | 0 | 0.00 |
2023-03-31 | 42.90 | 0 | 0.00 |
2022-12-31 | 51.30 | 0 | 0.00 |
2022-09-30 | 100.80 | 0 | 0.00 |
2022-06-30 | 121.14 | 0 | 0.00 |
2022-03-31 | 206.34 | 0 | 0.00 |
2021-12-31 | 199.20 | 0 | 0.00 |
2021-09-30 | 277.50 | 0 | 0.00 |
2021-06-30 | 357.00 | 0 | 0.00 |
2021-03-31 | 483.00 | 0 | 0.00 |
2020-12-31 | 624.00 | 0 | 0.00 |
2020-09-30 | 372.00 | 0 | 0.00 |
2020-06-30 | 384.00 | 0 | 0.00 |
2020-03-31 | 399.93 | 0 | 0.00 |
2019-12-31 | 675.00 | 0 | 0.00 |
2019-09-30 | 600.00 | 0 | 0.00 |
2019-06-30 | 654.00 | 0 | 0.00 |
2019-03-31 | 705.00 | 0 | 0.00 |
2018-12-31 | 465.00 | 0 | 0.00 |
2018-09-30 | 900.00 | 0 | 0.00 |
2018-06-30 | 1860.00 | 0 | 0.00 |
2018-03-31 | 3405.00 | 0 | 0.00 |
2017-12-31 | 4110.00 | 0 | 0.00 |
2017-09-30 | 5010.00 | 0 | 0.00 |
2017-06-30 | 4890.00 | 0 | 0.00 |
2017-03-31 | 6810.00 | 0 | 0.00 |
2016-12-31 | 3660.00 | 0 | 0.00 |
2016-09-30 | 8130.00 | 0 | 0.00 |
2016-06-30 | 10320.00 | 0 | 0.00 |
2016-03-31 | 10254.90 | 0 | 0.00 |
2015-12-31 | 22050.00 | 0 | 0.00 |
2015-09-30 | 59100.00 | 0 | 0.00 |
2015-06-30 | 86400.00 | 0 | 0.00 |
2015-03-31 | 93300.00 | 0 | 0.00 |
2014-12-31 | 92700.00 | 0 | 0.00 |
2014-09-30 | 66600.00 | 0 | 0.00 |
2014-06-30 | 191700.00 | 0 | 0.00 |
2014-03-31 | 234000.00 | 0 | 0.00 |
2013-12-31 | 222000.00 | 0 | 0.00 |
2013-09-30 | 216000.00 | 0 | 0.00 |
2013-06-30 | 276000.00 | 0 | 0.00 |
2013-03-31 | 276300.00 | 0 | 0.00 |
2012-12-31 | 444000.00 | 0 | 0.00 |
2012-09-30 | 630000.00 | 0 | 0.00 |
2012-06-30 | 714000.00 | 0 | 0.00 |
2012-03-31 | 510000.00 | 0 | 0.00 |
2011-12-31 | 264000.00 | 0 | 0.00 |
2011-09-30 | 762000.00 | 0 | 0.00 |
2011-06-30 | 780000.00 | 0 | 0.00 |
2011-03-31 | 1000000.00 | 0 | 0.00 |
2010-12-31 | 1000000.00 | $0.01 | 0.00 |
2010-09-30 | 1000000.00 | $0.01 | 0.00 |
2010-06-30 | 1000000.00 | $0.01 | 0.00 |
2010-03-31 | 1000000.00 | $0.01 | 0.00 |
2009-12-31 | 1000000.00 | 0 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.009B | $0.000B |
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
Boston Scientific (BSX) | United States | $151.510B | 37.93 |
Stryker (SYK) | United States | $148.668B | 31.08 |
EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
Medtronic (MDT) | Ireland | $113.608B | 16.10 |
Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
ResMed (RMD) | United States | $37.623B | 28.26 |
GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
Agilent Technologies (A) | United States | $34.375B | 22.41 |
Terumo (TRUMY) | Japan | $24.785B | 32.19 |
Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
Insulet (PODD) | United States | $20.867B | 81.91 |
Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
Baxter (BAX) | United States | $15.734B | 11.75 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.038B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.823B | 23.74 |
Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
Haemonetics (HAE) | United States | $3.650B | 16.62 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.415B | 28.38 |
ICU Medical (ICUI) | United States | $3.262B | 24.05 |
QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
AtriCure (ATRC) | United States | $1.566B | 0.00 |
Acuren (TIC) | United States | $1.379B | 0.00 |
AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
Neogen (NEOG) | United States | $1.137B | 14.56 |
BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
InMode (INMD) | Israel | $0.971B | 9.78 |
Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
Owens & Minor (OMI) | United States | $0.695B | 5.76 |
Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
CeriBell (CBLL) | United States | $0.619B | 0.00 |
Evolus (EOLS) | United States | $0.597B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
Valneva SE (VALN) | France | $0.497B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
Surmodics (SRDX) | United States | $0.429B | 0.00 |
SNDL (SNDL) | Canada | $0.363B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
Quanterix (QTRX) | United States | $0.327B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
Cerus (CERS) | United States | $0.279B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
ZimVie (ZIMV) | United States | $0.268B | 12.19 |
Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
Brainsway (BWAY) | Israel | $0.243B | 64.35 |
OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
Biote (BTMD) | United States | $0.222B | 6.25 |
TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
Organigram Global (OGI) | Canada | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
FitLife Brands (FTLF) | United States | $0.127B | 15.61 |
TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
Fonar (FONR) | United States | $0.097B | 12.47 |
MacroGenics (MGNX) | United States | $0.093B | 0.00 |
Jin Medical (ZJYL) | China | $0.091B | 0.00 |
Apyx Medical (APYX) | United States | $0.090B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
Zynex (ZYXI) | United States | $0.073B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Agape ATP (ATPC) | $0.069B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
ImmuCell (ICCC) | United States | $0.060B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.57 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.84 |
Safety Shot (SHOT) | United States | $0.032B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |